Codexis to Participate in Upcoming Healthcare Conferences

Rhea-AI Summary

Codexis (NASDAQ: CDXS), a leading enzyme engineering company, has announced its participation in two upcoming healthcare conferences. Management will engage in fireside chats at:

1. The Cantor Global Healthcare Conference in New York on September 17, 2024, at 11:30 am ET.

2. The Craig-Hallum Bioprocessing Conference (Virtual) on September 19, 2024, at 2:00 pm ET.

A live webcast of the Cantor fireside chat will be available on the company's Investor Relations website. A replay of the Craig-Hallum fireside chat will be accessible within 48 hours of the presentation. Both replays will be archived for at least 90 days following the presentation date.

News Market Reaction – CDXS

-0.70%

1 alert

-0.70% News Effect

On the day this news was published, CDXS declined 0.70%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

REDWOOD CITY, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that management will participate in two upcoming investor conferences.

The Cantor Global Healthcare Conference (New York, NY)

• Tuesday, September 17, 2024, at 11:30 am ET, management will participate in a fireside chat
  

The Craig-Hallum Bioprocessing Conference (Virtual)

• Thursday, September 19, 2024, at 2:00 pm ET, management will participate in a fireside chat
  

A live webcast of the Cantor fireside chat will be available in the Investor Relations section of the Company’s website, http://ir.codexis.com. A replay of the Craig-Hallum fireside chat will be available in the same location within 48 hours of the presentation. A replay of each will be archived for at least 90 days following the presentation date.

About Codexis

Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver^® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.

For More Information

Investor Contact
Carrie McKim
(336) 608-9706
ir@codexis.com

Media Contact
Lauren Musto
(650) 421-8205
media@codexis.com

FAQ

When is Codexis (CDXS) participating in the Cantor Global Healthcare Conference?

Codexis (CDXS) is participating in the Cantor Global Healthcare Conference on Tuesday, September 17, 2024, at 11:30 am ET in New York, NY.

What type of event is Codexis (CDXS) participating in at the Craig-Hallum Bioprocessing Conference?

Codexis (CDXS) management will participate in a fireside chat at the virtual Craig-Hallum Bioprocessing Conference on Thursday, September 19, 2024, at 2:00 pm ET.

Where can I watch the Codexis (CDXS) fireside chat from the Cantor Global Healthcare Conference?

A live webcast of the Codexis (CDXS) fireside chat from the Cantor Global Healthcare Conference will be available in the Investor Relations section of the company's website at http://ir.codexis.com.

How long will the replays of Codexis (CDXS) conference presentations be available?

Replays of both Codexis (CDXS) conference presentations will be archived for at least 90 days following the presentation date on the company's Investor Relations website.